Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data

Abstract

The availability of high-throughput molecular profiling techniques has provided more accurate and informative data for regular clinical studies. Nevertheless, complex computational workflows are required to interpret these data. Over the past years, the data volume has been growing explosively, requiring robust human data management to organise and integrate the data efficiently. For this reason, we set up an ELIXIR implementation study, together with the Translational research IT (TraIT) programme, to design a data ecosystem that is able to link raw and interpreted data. In this project, the data from the TraIT Cell Line Use Case (TraIT-CLUC) are used as a test case for this system. Within this ecosystem, we use the European Genome-phenome Archive (EGA) to store raw molecular profiling data; tranSMART to collect interpreted molecular profiling data and clinical data for corresponding samples; and Galaxy to store, run and manage the computational workflows. We can integrate these data by linking their repositories systematically. To showcase our design, we have structured the TraIT-CLUC data, which contain a variety of molecular profiling data types, for storage in both tranSMART and EGA. The metadata provided allows referencing between tranSMART and EGA, fulfilling the cycle of data submission and discovery; we have also designed a data flow from EGA to Galaxy, enabling reanalysis of the raw data in Galaxy. In this way, users can select patient cohorts in tranSMART, trace them back to the raw data and perform (re)analysis in Galaxy. Our conclusion is that the majority of metadata does not necessarily need to be stored (redundantly) in both databases, but that instead FAIR persistent identifiers should be available for well-defined data ontology levels: study, data access committee, physical sample, data sample and raw data file. This approach will pave the way for the stable linkage and reuse of data.

A Comprehensive Portal for Clinical and Translational Data Warehouses

“…This approach is not applicable in our context, however, as we aim to provide access to a wide range of data warehouses that integrate different types of data for different groups of users. Other groups have created portals by deeply integrating different types of applications managing different types of data (see, e.g., [9]). While this is different from our approach, the underlying mechanisms, e.g.…”

A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas

“…The Kaplan-Meier Plotter database [ 28 ] ( http://kmplot.com/analysis ) was constructed based on gene microarray and RNA-seq data from the gene expression omnibus (GEO) [ 29 ], European genome-phenome archive (EGA) [ 30 ], and TCGA public databases. We conducted a series of survival analyses of the relationships between SMARCA1 and various cancers to determine OS, relapse-free survival (RFS), distant metastasis-free survival (DMFS), post-progression survival (PPS), progress-free survival (PFS), first progression (FP) and disease-specific survival (DSS).…”

Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA–minus RNA sequencing data

“…Of the PCa-LINES samples, each sample was WGS DNA sequenced and processed using the Complete Genomics platform [ 24 , 57 ] (CompleteGenomics, San Jose, California, United States of America). The matching poly(A)+ RNA-seq samples were taken from the TraIT-Cell Line Use Case study [ 55 , 58 ]. rRNA-minus RNA-seq sample G-110 was not sequenced within PCa-LINEs but sequenced in NGS-ProToCol as sample 7046-004-052.…”